Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep438 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Clinical differences between patients with new-onset diabetes and those without it in a cohort of individuals with pancreatic cancer

Silva Vaca Carlos , Males David , Martin Gonzalez Alba , García Elena , Martínez Guillermo , León Miguel

Background: Pancreatic Cancer (PC) is uncommon; however, it is one of the most deadly cancer types of all. New-onset diabetes (NOD) is associated with a higher risk of pancreatic cancer than general population, particularly if late-onset. An association between new-onset diabetes and increased mortality in patients with pancreatic cancer has been suggested but clinical relevant differences between those individuals with new-onset diabetes and those without are not well establi...

ea0070aep1057 | Hot topics (including COVID-19) | ECE2020

Role of insulin aspart fiasp in patients with diabetes mellitus

León Utrero Sara , Serrano Laguna M del Carmen , Redondo Torres Enrique , Piedrola Maroto Gonzalo , Quesada Charneco Miguel

Introduction: Postprandial glycemic control is complex as well as insufficient. Its impact on global metabolic control (HbA1c) is controversial with various works that support its influence in terms of glycemic variability and genesis of micro and/or macrovascular complications. Fiasp due to its special formulation allows a more effective control of postprandial glycemia being an interesting alternative to the rapid-acting insulin analogavailable.Objecti...

ea0070aep1058 | Hot topics (including COVID-19) | ECE2020

Changes in metabolic control and body composition with Semaglutide sc in patients with type 2 diabetes mellitus

Redondo Enrique , Serrano Mª Carmen , Leon Sara , Andreo Mª Carmen , Sebastian Luisa , Quesada Miguel , Lopez-Ibarra Pablo

Objectives: aGLP1 have been positioned as an effective and safe treatment in patients with Type 2 Diabetes Mellitus (DM2). The objective was to evaluate the changes metabolic and body composition at 6 months after initiation with Semaglutide weekly subcutaneous added to its basic treatment in patients with DM2.Material and Methods: Prospective observational study. Treatment was started in 42 patients with DM2, with weekly subcutaneous Semaglutide with a ...

ea0070ep107 | Bone and Calcium | ECE2020

Ectopic parathyroid hormone secretion by a squamous cell carcinoma of the floor of the mouth with poor response to cinacalcet

Bilbao Ismene , Egaña Nerea , Rojo Jorge , Garcia Cristina , Olaizola Izaskun , Agea Leire , Aranburu Maite , Yoldi Alfredo , Goena Miguel

Introduction: Ectopic PTH secretion is rare, to our knowledge, with only 27 cases reported in the literature and 3, ( a tonsil, a lung and a penile) due to squamous cell carcinoma .In the few cases reported to date it appears to be more common in males and in those over the age of 60. The management of the hypercalcemia in this setting is complicated. We are aware of 2 other case reports in which cinacalcet was used in this context, but as in our case, unsuccessfully.<p cl...

ea0032p131 | Calcium and Vitamin D metabolism | ECE2013

Predictive factors of postoperative hypoparathyroidism after total thyroidectomy

Paja Miguel , Etxeberria Eider , Calles Laura , Exposito Amaia , Ugarte Estibaliz , Moreno Cristina , Lizarraga Aitzol , Espiga Javier , Oleaga Amelia

Introduction: Hypoparathyroidism (hypoPT) is the most frequent complication after thyroid surgery, usually as transient hypocalcaemia. Permanent parathyroid lesion is less frequent, but it can extend hospital stay and complicate postoperative management. Several preoperative factors predicting the development of hypoPT have been identified, including advanced age, hyperthyroidism, surgical experience and others. We evaluate the role of some potentially predictive factors in ou...

ea0032p233 | Clinical case reports – Pituitary/Adrenal | ECE2013

Good response to temozolamide therapy in a man with a prolactin secreting pituitary carcinoma

Bilbao Ismene , Coca Mariano Alvarez , Garcia Cristina , Egana Nerea , Aranburu Maite , Yoldi Alfredo , Antunano Luisa , Goena Miguel

Introduction: Pituitary carcinomas are rare and their management is difficult, because they exhibit a continued growth and metastatic dissemination despite of multimodal and aggressive treatments. Temozolamide, has shown a substantial response rates in pituitary carcinomas.We report the case of a patient with a malignant prolactinoma successfully treated with temozolamide.Case report: The patient, a 62-year-old male, consulted with...

ea0032p364 | Diabetes | ECE2013

Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet

Beiroa Daniel , Amparo Romero-Pico , Carmen Langa , Carmelo Bernabeu , Miguel Lopez , Lopez-Novoa Jose M , Ruben Nogueiras , Carlos Dieguez

Introduction: Endoglin is a transmembrane auxiliary receptor for transforming growth factor-β (TGF-β) that is predominantly expressed on proliferating endothelial cells. It plays a wide range of physiological roles but its importance on energy balance or insulin sensitivity has been unexplored.Material and methods: Heterozygous deficient mice (HZ) were fed standard chow or high fat diet during 16 weeks. Blood glucose levels were measured after ...

ea0032p714 | Neuroendocrinology | ECE2013

Central diabetes insipidus, as the first sign of Langerhans cell histiocytosis in an adult

Egana Nerea , Ruiz Irune , Bilbao Ismene , Aramburu Maite , Yoldi Alfredo , Garcia Cristina , Alvarez Coca Mariano , Luisa Antunano Maria , Goena Miguel

Introduction: Langerhans cell histiocytosis (LCH) is a rare granulomatous disease of unknown etiology. LCH may be localized or be a systemic disease. The diagnosis is frecuent in pediatric age. In adults, infiltration is most frecuently in bones, lungs and skin, and shows particular predilection for hypothalamo-pituitary axis.Case: A 51 years old man was referred due to polyuria of ~15 l of daily urine output. His past medical history revealed bronchiect...

ea0032p1065 | Thyroid (non-cancer) | ECE2013

Subclinical autoimmune thyroid disease and cardiovascular risk factors

Neves Celestino , Esteves Cesar , Pereira Miguel , Palmares Carmo , Sokhatsha Oksana , Dias Camila , Delgado Luis , Carvalho Davide , Luis Medina Jose

Objective: To examine whether Graves’ disease (GD) and autoimmune thyroiditis (AIT) are associated with insulin resistance and other cardiovascular risk factors.Subjects and methods: We recorded thyroid function tests, BMI, insulin resistance markers comprising the homeostasis model assessment for insulin resistance (HOMA-IR and HOMA-B), the quantitative insulin sensitivity check index (QUICKI), hepatic insulin sensitivity index (HISI), whole-body i...

ea0032p1066 | Thyroid (non-cancer) | ECE2013

Subclinical hypothyroidism, autoimmune thyroiditis, and cardiovascular risk factors

Pereira Teresa , Neves Celestino , Esteves Cesar , Camila Dias Claudia , Pereira Miguel , Sokhatska Oksana , Delgado Luis , Carvalho Davide , Luis Medina Jose

Aim: To evaluate the relationship between autoimmune thyroiditis (AIT), subclinical hypothyroidism (SCH) and cardiovascular risk factors.Patients and methods: We recorded thyroid function tests, BMI, insulin resistance markers comprising the homeostasis model assessment for insulin resistance (HOMA-IR and HOMA-B), the quantitative insulin sensitivity check index (QUICKI), hepatic insulin sensitivity index (HISI), whole-body insulin sensitivity index (WBI...